To further investigate the clinical implications of FAP+ fibroblasts in promoting PCa progression, we compared overall survival (OS), disease‐free survival (DFS), and progression‐free interval (PFI) between patients with different levels of FAP+ fibroblasts. The gene discussed is FAP; the disease is posterior cortical atrophy.